Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 200 of 768 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/16/23
End: 06/30/25
Due: 06/30/26
Phase: N/A
Priority: Normal
Start: 03/28/17
End: 04/17/19
Due: 04/17/20
Phase: N/A
Priority: Normal
Start: 06/18/18
End: 10/16/19
Due: 10/16/20
Phase: N/A
Priority: Normal
Start: 06/30/14
End: 12/31/21
Due: 12/31/22
Phase: N/A
Priority: Normal
Start: 03/31/13
End: 09/30/16
Due: 09/30/17
Phase: N/A
Priority: Normal
Start: 04/30/07
End: 11/30/13
Due: 11/30/14
Phase: N/A
Priority: Normal
Start: 09/30/14
End: 04/30/17
Due: 04/30/18
Phase: N/A
Priority: Normal
Start: 10/31/08
End: 10/31/10
Due: 10/31/11
Phase: N/A
Priority: Normal
Start: 05/31/15
End: 04/30/19
Due: 04/30/20
Phase: N/A
Priority: Normal
Start: 07/10/15
End: 12/31/17
Due: 12/31/18
Phase: N/A
Priority: Normal
Start: 12/13/24
End: 10/10/32
Due: 10/10/33
A Trial of Obinutuzumab,GDC-0199 Plus Ibrutinib in Relapsed/Refractory Mantle Cell Lymphoma Patients
Phase: N/A
Priority: Normal
Start: 10/14/15
End: 10/31/25
Due: 10/31/26
Phase: N/A
Priority: Normal
Start: 06/30/09
End: 12/31/12
Due: 12/31/13
Phase: N/A
Priority: Normal
Start: 04/24/20
End: 07/02/20
Due: 07/02/21
Phase: N/A
Priority: Normal
Start: 05/02/23
End: 05/31/26
Due: 05/31/27
Phase: N/A
Priority: Normal
Start: 09/30/13
End: 08/31/16
Due: 08/31/17
Phase: N/A
Priority: Normal
Start: 02/05/21
End: 09/23/24
Due: 09/23/25
Phase: N/A
Priority: Normal
Start: 01/31/13
End: 12/31/14
Due: 12/31/15
Phase: N/A
Priority: Normal
Start: 01/31/09
End: 05/31/10
Due: 05/31/11
Phase: N/A
Priority: Normal
Start: 11/07/21
End: 07/31/23
Due: 07/31/24
Phase: N/A
Priority: Normal
Start: 09/30/08
End: 02/28/14
Due: 02/28/15
Phase: N/A
Priority: Normal
Start: 10/31/13
End: 08/31/15
Due: 08/31/16
Phase: N/A
Priority: Normal
Start: 10/31/12
End: 09/30/14
Due: 09/30/15
Phase: N/A
Priority: Normal
Start: 09/15/17
End: 12/15/18
Due: 12/15/19
Phase: N/A
Priority: Normal
Start: 03/01/25
End: 07/01/28
Due: 07/01/29